Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation.
about
Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growthB7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinomaMesenchymal Stem Cells and Myeloid Derived Suppressor Cells: Common Traits in Immune RegulationNovel technologies and emerging biomarkers for personalized cancer immunotherapyTargeting Epigenetic Processes in Photodynamic Therapy-Induced Anticancer ImmunityThe influence of early neutrophil-Leishmania interactions on the host immune response to infectionHampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancerReciprocal relationship between myeloid-derived suppressor cells and T cellsImmune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differencesMyeloid-derived suppressor cells as regulators of the immune systemStromal cell-derived factor-1/CXCL12 contributes to MMTV-Wnt1 tumor growth involving Gr1+CD11b+ cellsImmunosuppressive networks in the tumour environment and their therapeutic relevanceIncreased degradation of extracellular matrix structures of lacrimal glands implicated in the pathogenesis of Sjögren's syndrome.Mast cells mobilize myeloid-derived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma modelMyeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells.Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer.Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine.The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy.Histone modifications are associated with Δ9-tetrahydrocannabinol-mediated alterations in antigen-specific T cell responsesTim-3/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells.CD11b⁺, Ly6G⁺ cells produce type I interferon and exhibit tissue protective properties following peripheral virus infectionCentral role for interleukin-4 in regulating nitric oxide-mediated inhibition of T-cell proliferation and gamma interferon production in schistosomiasisTumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells.Chronic intake of high fish oil diet induces myeloid-derived suppressor cells to promote tumor growth.Paired immunoglobin-like receptor-B regulates the suppressive function and fate of myeloid-derived suppressor cells.Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive propertiesAdoptive transfer of HER2/neu-specific T cells expanded with alternating gamma chain cytokines mediate tumor regression when combined with the depletion of myeloid-derived suppressor cellsLPS-induced CD11b+Gr1(int)F4/80+ regulatory myeloid cells suppress allergen-induced airway inflammation.All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients.Anti-CD40-induced inflammatory E-cadherin+ dendritic cells enhance T cell responses and antitumour immunity in murine Lewis lung carcinomaEffects of allogeneic hematopoietic stem cell transplantation plus thymus transplantation on malignant tumors: comparison between fetal, newborn, and adult miceMyeloid-derived suppressor cells regulate T cell and B cell responses during autoimmune diseaseMyeloid-derived suppressor cells prevent type 1 diabetes in murine modelsDensity of Gr1-positive myeloid precursor cells, p-STAT3 expression and gene expression pattern in canine mammary cancer metastasis.The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies.Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells.Dopamine inhibits the function of Gr-1+CD115+ myeloid-derived suppressor cells through D1-like receptors and enhances anti-tumor immunity.Complexity and challenges in defining myeloid-derived suppressor cellsImmune biasing by helminth glycans.A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1.
P2860
Q21560837-34B89655-CD18-4C19-95B9-AEBFF839B868Q24676809-1633A638-76F2-49D5-BCA1-144591619C5AQ26741252-996E5DCF-CC08-4D56-93FC-03F05B467C8EQ26770780-8DCB5BAB-FE1B-4BB9-A32E-D751311A8B02Q26797280-9AF5410A-AF2A-4DD4-B9E2-815B3CC3B5D8Q26823114-FEFEA560-76D6-4BE2-9231-5DD828F1E59FQ26863418-E984E604-09E1-432A-8101-545EEDD70B54Q27000664-ED5DB678-A42F-49BA-A99D-503277734803Q27027064-0E61F481-2637-4C95-BD00-87B0CE489970Q28131637-F37F2F4B-48CC-495B-9A44-D8DB112C9A68Q28749398-7F3BA841-26F5-4121-8D27-2C1CC2AFF09FQ29619244-BF4636C7-211F-4531-B717-09FD5DB45C38Q30833276-E0A7FFA1-5752-44A9-B100-1280AE82A2EEQ33527427-6BE5C277-726C-4131-AE85-4F232ABCE9CEQ33567728-1F86F969-7521-4A98-9CA1-6D9F95F346C8Q33584851-206A1BE4-58AE-45F7-99BE-C4E2D0E5AA59Q33584867-52B2DE03-5A60-47C5-82FA-226F76716F91Q33660069-72F1D5A3-890D-4F4E-BC3A-183A1CEE242CQ33846410-C7D9860E-1CE0-49F0-B007-A5008A7E2426Q34078014-05A4AB81-8855-4341-8659-82D865880A4DQ34079167-7A2BCD55-DE69-4375-AAC4-997C5A8CBEACQ34115626-11479A6F-652E-44AB-847E-0A08B6DD7078Q34312635-48C534E7-6732-4857-8846-414E14B6255CQ34579989-98EF3C27-13FB-4692-8EB1-FB7F48F9CC8CQ34723007-01E7F870-962B-44AB-83A0-80F6E464806FQ34789214-0AF22934-127C-4ED2-8711-9949854393B9Q34877332-FFD51CA9-443D-4C4A-9BB6-2C73C5F9DEF5Q35028319-E0BC7DD5-AE8A-4FE5-BA32-C8503D9D0487Q35062106-641361AC-CFDC-4836-BD39-89C58FA93172Q35068131-18788E6A-C18B-4BF9-A3E2-41C62F57F1A4Q35084095-3817E7FB-A059-4D3B-A7AD-96E0B80A76BFQ35115477-15687947-29F1-4EDE-A9AD-B49325D6588EQ35166486-AD078427-A5D9-41FE-8FF1-B690174BE8D2Q35191027-985DFBFD-EBD0-4BE7-9337-D83FCB201536Q35207756-AA5CCD19-5B77-4BA8-86DB-5E752C3FC635Q35207759-527ED507-1D40-4B93-9ECD-4CD3A7564C7FQ35227738-5058D6CB-058B-4087-A33D-5FE050E0BED0Q35509317-DE94A369-D7D8-4214-8DA5-B6B2FD187370Q35608898-271465A0-A8C6-4112-9292-5F1C5F50C1A8Q35640574-B30AE428-666F-4401-A85B-7F76CDD39866
P2860
Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Gr-1+ myeloid cells derived fr ...... hrough CD3/CD28 costimulation.
@en
Gr-1+ myeloid cells derived fr ...... hrough CD3/CD28 costimulation.
@nl
type
label
Gr-1+ myeloid cells derived fr ...... hrough CD3/CD28 costimulation.
@en
Gr-1+ myeloid cells derived fr ...... hrough CD3/CD28 costimulation.
@nl
prefLabel
Gr-1+ myeloid cells derived fr ...... hrough CD3/CD28 costimulation.
@en
Gr-1+ myeloid cells derived fr ...... hrough CD3/CD28 costimulation.
@nl
P2093
P1476
Gr-1+ myeloid cells derived fr ...... hrough CD3/CD28 costimulation.
@en
P2093
P304
P356
10.4049/JIMMUNOL.165.2.779
P407
P577
2000-07-01T00:00:00Z